You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
5 April 2024
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications
8 November 2023
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
31 July 2023
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
27 July 2023
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026
10 July 2023
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
2 May 2023
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
+49.2173.8955.4900